Smith & Wesson Brands, Inc. is a US-listed company in the leisure products industry. Its financial year ends in April.
Loading chart…
Third-party market data · may be delayed
~$5.5
Cash-flow model
Base case. Range ~$4.2–$7.1 across our lower- and higher-growth cases (4.8%–14.8% a year).
Overvalued
The price is above our entire value range; our base value is 59% below it.
Price used: $13.25, November 2, 2026
Smith & Wesson Brands, Inc. valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months to July 2026 was $551m, up 17.0% on a year earlier, faster than the 10.4% growth a quarter earlier. Free-cash-flow margin rose to 14.9% from -1.3% a year earlier. It passes 2 of our 2 financial-health checks. Our cash-flow model value is $5.75 a share, against a share price of $13.71.
Source: 10-Q filed September 3, 2026 on SEC EDGAR · Financials · Valuation
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Smith & Wesson Brands, Inc.'s trailing-twelve-month revenue grew 17.0% year on year, with a free-cash-flow margin of 14.9%.
Our discounted-cash-flow model values the business at ~$5.5 per share in the base case (~$4.2–$7.1 across growth scenarios) — model values under stated assumptions, not a price target.
Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 220% in the quarter to 2026-07-31, the 4th beat in the last four quarters.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
The share price implies about 26.0% a year of cash-flow growth for five years.That is faster than the -8.6% a year revenue growth Smith & Wesson Brands has delivered.
Read with care: free cash flow has swung sharply in the past year (often a one-off tax, legal or working-capital item), so the cash-flow base behind this reading may be unusually low or high.
Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($13.22, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies
Our value per share comes from a discounted-cash-flow model of Smith & Wesson Brands, Inc.'s free cash flow after stock-based pay ( $9.2M, FY2027 Q1 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.
We value Smith & Wesson Brands, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 8.5%: the 10-year Treasury yield (4.9%) plus a beta of 0.79 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. | ~$5.5 ~$4.2–$7.1 | Primary model, counts double |
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | ~$9.4 ~$7.6–$13 | Included |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$13 ~$9.9–$19 | Included |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$15 ~$13–$19 | Included |
| Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$9.9 ~$5.5–$15 | 4 models |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Smith & Wesson Brands, Inc. with Leisure Products in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
| Discount rate ↓ / growth → | −5% growth | 0% growth | 5% growth | 10% growth | 15% growth | 20% growth |
|---|---|---|---|---|---|---|
| 7% | $3 | $4 | $6 | $8 | $10 | $13 |
| 8.5% | $3 | $3 | $4 | $6 | $8 | $10 |
| 10% | $2 | $3 | $4 | $5 | $6 | $8 |
| At fiscal year end | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | $13.59 | $13.79 | $6.85 | $6.13 | $5.90 | $14.22 | $11.40 | $10.36 | $15.15 | $8.89 | $15.25 |
| Market value | $761m | $785m | $376m | $339m | $328m | $787m | $544m | $478m | $700m | $400m | $685m |
| + Net debt (− = net cash) | −$18m | $107m | −$49m | −$41m | −$125m | −$113m | −$121m | −$54m | −$61m | −$25m | −$28m |
| Enterprise value | $742m | $891m | $327m | $298m | $203m | $674m | $423m | $425m | $640m | $374m | $657m |
| Multiples | |||||||||||
| Price / sales | 1.1x | 0.9x | 0.6x | 0.7x | 0.6x | 0.7x | 0.6x | 1.0x | 1.3x | 0.8x | 1.3x |
| Price / earnings | 8.1x | 6.1x | 18.7x | 18.4x | — | 3.1x | 2.8x | 13.0x | 16.9x | 29.8x | 37.1x |
| Price / free cash flow | 5.5x | 8.8x | 8.7x | 12.9x | 4.0x | 2.7x | 4.8x | — | 43.8x | — | 7.6x |
| EV / EBITDA | 3.7x | 3.6x | 4.1x | 4.1x | 2.5x | 1.9x | 1.5x | 5.3x | 8.0x | 6.7x | 10.9x |
Moderate moat
How hard Smith & Wesson Brands's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
Cash operating profit has been a median 13.3% of total assets over 10 years.
Gross margin has been a median 34.0%, moving by 5.6 percentage points (standard deviation) across 10 years.
Operating margin has been a median 8.8%; its worst year was 4.8%.
Free cash flow was positive in 6 of 10 years, at a median 1.9% of revenue.
The diluted share count fell 16.1% over five years; stock-based pay has been a median 1.1% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (62 before it).
Next results: December 3, 2026, after the close. Analysts expect revenue of $136m and EPS of $0.08 (range $0.08 to $0.08) for the quarter.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $0.55 | +34% | $559m | +7% |
| Next | $0.60 | +9% | $572m | +2% |
The consensus EPS forecast for the current fiscal year is +66.7% on 90 days ago. In the last 30 days, 1 analyst raised Smith & Wesson Brands, Inc.'s forecast and 0 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year |
|---|---|
| 90 days ago | $0.33 |
| 60 days ago | $0.47 |
| 30 days ago | $0.47 |
| 7 days ago | $0.47 |
| Now | $0.55 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | −$0.05 | $0.06 | +220.0% |
| Apr 2026 | $0.23 | $0.36 | +56.5% |
| Jan 2026 | $0.05 | $0.08 | +60.0% |
| Oct 2025 | $0.02 | $0.04 | +100.0% |
Adjusted EPS as companies report it, against the average analyst estimate.
Our cash-flow model grows Smith & Wesson Brands, Inc.'s revenue by +6.3% next year and +8.8% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+2.1%, weight 45%) and the company's own record (+9.8%, weight 55%) . How the weights are set.
Last 12 months +43.9%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $471m | $551m | +17.0% |
| Net margin | 2.5% | 4.4% | +76.3% |
| P/E multiple | 34.7x | 24.3x | −30.0% |
| Share count | 45m | 45m | −0.3% |
Biggest factor: net margin.
Last 3 years +4.1%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $509m | $551m | +8.3% |
| Net margin | 7.2% | 4.4% | −38.4% |
| P/E multiple | 16.0x | 24.3x | +51.4% |
| Share count | 46m | 45m | +3.0% |
Biggest factor: net margin.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| SWBI | +2% | −50% | +62% | −23% | +3% | +38% |
| Industry peers (median) | +17% | −35% | −8% | −26% | −15% | +3% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| SWBI | 58% | 42% | 42% | 33% | 50% | 55% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| SWBI | −54% | −54% | −22% | −44% | −29% | −26% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since October 29, 2015: 82% from August 1, 2016 to October 3, 2019. Getting back needed a 440% gain, reached on June 18, 2021, 624 days after the low.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| September 3, 2026 | +0.9% | +0.7% | +2.9% | +16.2% |
| June 17, 2026 | +15.8% | −0.2% | +13.0% | +9.1% |
| March 5, 2026 | +16.5% | −1.9% | +15.7% | +24.1% |
| December 4, 2025 | +23.4% | +0.3% | +23.9% | +16.9% |
| September 4, 2025 | +9.0% | +0.5% | +17.1% | +25.3% |
| June 18, 2025 | −16.8% | −0.2% | −16.9% | −23.7% |
| March 6, 2025 | −9.1% | −1.2% | −9.1% | −14.2% |
| December 5, 2024 | −23.0% | 0.0% | −21.3% | −28.6% |
| September 5, 2024 | −9.8% | −1.9% | −9.7% | −8.9% |
| June 20, 2024 | −12.5% | −0.4% | −9.5% | −5.7% |
| March 7, 2024 | +32.0% | +0.4% | +31.8% | +35.7% |
| December 7, 2023 | −11.3% | +1.2% | −8.2% | −5.2% |
How Smith & Wesson Brands, Inc.’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.
A results date falls inside these options’ life. Implied volatility is meant to be higher for that, so we do not call it rich.
Our rule for “rich”: implied at least 1.2× 60-day realised (beyond measurement noise), above 1-year realised (not just a calm spell), and in the top 20% of our coverage that day. Never with results inside the option’s life. These are our conventions, built on research showing option prices usually imply more movement than follows, most when the gap is wide. How we judge this.
Not offered: rated Sell.
We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.
Own 100 shares, sell the $15.00 call expiring December 18, 2026 (46 days) for $0.35 a share — $35.00 per contract.
Previous session · Bid $0.35, ask $0.45, quoted Mon 2 Nov, 17:37 New York time with SWBI at $13.23. Option prices move with the shares: check the live chain at your broker before trading.
Results are expected around December 3, 2026, before this option expires: the share price can jump on results, and the premium partly reflects that.
Own the shares, buy the $13.00 put and sell the $15.00 call, both expiring December 18, 2026 (46 days).
Offered because the shares trade at or above our fair value of $5.50: a way to hold on with a floor under the price, paid for by giving up upside the model does not expect. Strikes near 25-delta; the put at its ask and the call at its bid. Protection has a cost over time: research on protective puts finds they have usually lowered returns.
General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY24 Q2 | $513M |
| FY24 Q3 | $521.5M |
| FY24 Q4 | $535.8M |
| FY25 Q1 | $509.9M |
| FY25 Q2 | $514.6M |
| FY25 Q3 | $493M |
| FY25 Q4 | $474.7M |
| FY26 Q1 | $471.4M |
| FY26 Q2 | $466.4M |
| FY26 Q3 | $486.2M |
| FY26 Q4 | $523.8M |
| FY27 Q1 | $551.4M |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY24 Q2 | -9.1% |
| FY24 Q3 | 1.1% |
| FY24 Q4 | 11.8% |
| FY25 Q1 | 0.2% |
| FY25 Q2 | 0.3% |
| FY25 Q3 | -5.4% |
| FY25 Q4 | -11.4% |
| FY26 Q1 | -7.6% |
| FY26 Q2 | -9.4% |
| FY26 Q3 | -1.4% |
| FY26 Q4 | 10.4% |
| FY27 Q1 | 17.0% |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | Operating margin (TTM) |
|---|---|
| FY24 Q2 | 7.8% |
| FY24 Q3 | 7.1% |
| FY24 Q4 | 8.8% |
| FY25 Q1 | 8.1% |
| FY25 Q2 | 8.7% |
| FY25 Q3 | 7.8% |
| FY25 Q4 | 5.0% |
| FY26 Q1 | 4.8% |
| FY26 Q2 | 4.1% |
| FY26 Q3 | 4.3% |
| FY26 Q4 | 5.6% |
| FY27 Q1 | 6.6% |
Source: SEC EDGAR filings. Retrieved October 29, 2026.
| Period | FCF margin (TTM) |
|---|---|
| FY24 Q2 | -6.8% |
| FY24 Q3 | -1.8% |
| FY24 Q4 | 2.9% |
| FY25 Q1 | -5.5% |
| FY25 Q2 | -0.2% |
| FY25 Q3 | -4.9% |
| FY25 Q4 | -6.1% |
| FY26 Q1 | -1.3% |
| FY26 Q2 | 4.5% |
| FY26 Q3 | 11.1% |
| FY26 Q4 | 17.2% |
| FY27 Q1 | 14.9% |
Each dollar Smith & Wesson Brands took in during FY2026, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.
| Revenue | $524M | |
|---|---|---|
| Cost of revenue | $383M | 73.1% of revenue |
| Gross profit | $141M | 26.9% of revenue |
| Research and development | $10.3M | 2.0% of revenue |
| Selling, general and admin | $102M | 19.4% of revenue |
| Operating income | $29.2M | 5.6% of revenue |
| Income tax | $6.6M | 1.3% of revenue |
| Interest and other | $4.1M | 0.8% of revenue |
| Net income | $18.5M | 3.5% of revenue |
| Fiscal year | 2010 Apr 2010 | 2011 Apr 2011 | 2012 Apr 2012 | 2013 Apr 2013 | 2014 Apr 2014 | 2015 Apr 2015 | 2016 Apr 2016 | 2017 Apr 2017 | 2018 Apr 2018 | 2019 Apr 2019 | 2020 Apr 2020 | 2021 Apr 2021 | 2022 Apr 2022 | 2023 Apr 2023 | 2024 Apr 2024 | 2025 Apr 2025 | 2026 Apr 2026 | LTM Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||
| Revenue | 358 | 342 | 412 | 588 | 627 | 552 | 723 | 903 | 607 | 481 | 530 | 1,059 | 864 | 479 | 536 | 475 | 524 | 551 |
| Gross profit | 119 | 105 | 128 | 218 | 259 | 195 | 294 | 375 | 196 | 146 | 166 | 449 | 375 | 155 | 158 | 127 | 141 | 151 |
| EBITDA | 54 | 31 | 60 | 150 | 173 | 121 | 200 | 250 | 79 | 73 | 82 | 351 | 282 | 80 | 80 | 56 | 61 | 67 |
| Operating income | 40 | 18 | 45 | 133 | 151 | 90 | 159 | 200 | 27 | 44 | 50 | 320 | 252 | 48 | 47 | 24 | 29 | 36 |
| Net income | 33 | −83 | 16 | 79 | 89 | 50 | 94 | 128 | 20 | 18 | −61 | 252 | 194 | 37 | 41 | 13 | 18 | 24 |
| Diluted EPS | — | −$1.30 | $0.25 | $1.18 | $1.49 | $0.90 | $1.68 | $2.25 | $0.37 | $0.33 | −$1.10 | $4.55 | $4.08 | $0.80 | $0.89 | $0.30 | $0.41 | — |
| Growth (year on year) | ||||||||||||||||||
| Revenue | — | −4.4% | +20.4% | +42.6% | +6.7% | −11.9% | +31.0% | +24.9% | −32.8% | −20.7% | +10.0% | +100.0% | −18.4% | −44.5% | +11.8% | −11.4% | +10.4% | +17.0% |
| EBITDA | — | −42.2% | +94.7% | +147.6% | +15.5% | −30.2% | +65.8% | +25.2% | −68.4% | −8.3% | +13.4% | +326.9% | −19.8% | −71.7% | −0.2% | −30.0% | +8.6% | +22.5% |
| Operating income | — | −55.6% | +152.5% | +195.7% | +13.7% | −40.6% | +77.0% | +26.0% | −86.5% | +60.9% | +15.6% | +535.4% | −21.3% | −80.8% | −2.7% | −49.3% | +22.3% | +62.1% |
| Net income | — | −354.6% | — | +388.7% | +13.5% | −44.4% | +89.4% | +36.1% | −84.3% | −8.5% | −432.6% | — | −22.8% | −81.0% | +12.2% | −67.5% | +37.7% | +106.2% |
| Diluted EPS | — | — | — | +372.0% | +26.3% | −39.6% | +86.7% | +33.9% | −83.6% | −10.8% | −433.3% | — | −10.3% | −80.4% | +11.3% | −66.3% | +36.7% | — |
| Margins | ||||||||||||||||||
| Gross margin | 33.4% | 30.6% | 31.0% | 37.1% | 41.3% | 35.3% | 40.6% | 41.5% | 32.3% | 30.4% | 31.3% | 42.4% | 43.3% | 32.2% | 29.5% | 26.8% | 26.9% | 27.4% |
| EBITDA margin | 15.0% | 9.1% | 14.7% | 25.5% | 27.6% | 21.8% | 27.6% | 27.7% | 13.0% | 15.1% | 15.5% | 33.2% | 32.6% | 16.7% | 14.9% | 11.7% | 11.6% | 12.1% |
| Operating margin | 11.2% | 5.2% | 10.9% | 22.6% | 24.1% | 16.2% | 21.9% | 22.1% | 4.5% | 9.0% | 9.5% | 30.2% | 29.1% | 10.1% | 8.8% | 5.0% | 5.6% | 6.6% |
| Net margin | 9.1% | −24.2% | 3.9% | 13.4% | 14.3% | 9.0% | 13.0% | 14.2% | 3.3% | 3.8% | −11.6% | 23.8% | 22.5% | 7.7% | 7.7% | 2.8% | 3.5% | 4.4% |
| Free-cash-flow margin | 1.7% | 5.4% | 5.7% | 9.6% | 5.9% | 15.7% | 19.2% | 9.8% | 7.1% | 5.4% | 15.5% | 27.7% | 13.2% | −15.2% | 3.0% | −6.1% | 17.3% | 14.9% |
| Cash flow | ||||||||||||||||||
| Cash from operations | 23 | 38 | 37 | 98 | 90 | 115 | 169 | 124 | 62 | 57 | 95 | 315 | 138 | 17 | 107 | −7 | 114 | 113 |
| Capital spending | 17 | 20 | 14 | 41 | 53 | 28 | 29 | 35 | 18 | 31 | 12 | 22 | 24 | 90 | 91 | 22 | 24 | 31 |
| Free cash flow | 6 | 19 | 24 | 57 | 37 | 87 | 139 | 89 | 43 | 26 | 82 | 293 | 114 | −73 | 16 | −29 | 90 | 82 |
| Stock-based pay | 3 | 2 | 2 | 4 | 8 | 6 | 6 | 9 | 8 | 7 | 2 | 5 | 5 | 5 | 6 | 8 | 8 | 8 |
| Free cash flow after stock pay | 3 | 17 | 21 | 53 | 29 | 81 | 133 | 80 | 35 | 19 | 80 | 289 | 109 | −78 | 10 | −36 | 82 | 74 |
| Balance sheet | ||||||||||||||||||
| Cash | 40 | 58 | 57 | 100 | 69 | 42 | 191 | 62 | 49 | 41 | 125 | 113 | 121 | 54 | 61 | 25 | 28 | 19 |
| Total debt | 0 | 80 | 50 | 44 | 100 | 171 | 173 | 168 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net debt (negative = net cash) | −40 | 22 | −7 | −57 | 31 | 129 | −18 | 107 | −49 | −41 | −125 | −113 | −121 | −54 | −61 | −25 | −28 | −19 |
| Diluted shares | 65m | 64m | 67m | 67m | 60m | 55m | 56m | 57m | 55m | 55m | 56m | 55m | 48m | 46m | 46m | 45m | 45m | — |
| Returned to shareholders | ||||||||||||||||||
| Dividends | — | — | — | — | — | — | — | — | — | — | 0 | 8 | 15 | 18 | 22 | 23 | 23 | 23 |
| Buybacks | — | — | — | 20 | 116 | 30 | — | 50 | — | — | 0 | 110 | 90 | 0 | 10 | 25 | 0 | — |
| Total returned | — | — | — | 20 | 116 | 30 | — | 50 | — | — | 0 | 118 | 105 | 18 | 32 | 49 | 23 | 23 |
| Quarter | 2025 Q2 Oct 2024 | 2025 Q3 Jan 2025 | 2025 Q4 Apr 2025 | 2026 Q1 Jul 2025 | 2026 Q2 Oct 2025 | 2026 Q3 Jan 2026 | 2026 Q4 Apr 2026 | 2027 Q1 Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 130 | 116 | 141 | 85 | 125 | 136 | 178 | 113 |
| Gross profit | 35 | 28 | 41 | 22 | 30 | 36 | 53 | 32 |
| EBITDA | 16 | 12 | 21 | 5 | 12 | 14 | 29 | 12 |
| Operating income | 8 | 5 | 13 | −3 | 4 | 7 | 21 | 4 |
| Net income | 5 | 2 | 9 | −3 | 2 | 4 | 16 | 3 |
| Diluted EPS | $0.10 | $0.05 | $0.19 | −$0.08 | $0.04 | $0.08 | $0.36 | $0.06 |
| Growth (year on year) | ||||||||
| Revenue | +3.8% | −15.7% | −11.6% | −3.7% | −3.9% | +17.1% | +26.7% | +32.3% |
| EBITDA | +33.0% | −32.3% | −41.3% | −16.0% | −22.9% | +13.0% | +37.1% | +117.6% |
| Operating income | +100.0% | −57.9% | −52.6% | — | −45.4% | +41.5% | +62.6% | — |
| Net income | — | −73.3% | −69.0% | — | −57.8% | — | +87.9% | — |
| Diluted EPS | — | −70.6% | −68.3% | — | −60.0% | — | +89.5% | — |
| Margins | ||||||||
| Gross margin | 26.6% | 24.1% | 28.8% | 25.9% | 24.3% | 26.2% | 29.8% | 28.7% |
| EBITDA margin | 12.1% | 10.7% | 15.0% | 6.4% | 9.7% | 10.3% | 16.2% | 10.6% |
| Operating margin | 5.8% | 4.1% | 9.3% | −3.5% | 3.3% | 4.9% | 12.0% | 3.7% |
| Net margin | 3.5% | 1.8% | 6.1% | −4.0% | 1.5% | 2.8% | 9.1% | 2.3% |
| Free-cash-flow margin | −8.3% | −13.9% | 23.8% | −14.6% | 13.1% | 12.4% | 39.1% | −18.5% |
| Cash flow | ||||||||
| Cash from operations | −7 | −10 | 41 | −8 | 27 | 20 | 75 | −9 |
| Capital spending | 3 | 6 | 7 | 4 | 11 | 4 | 5 | 12 |
| Free cash flow | −11 | −16 | 34 | −12 | 16 | 17 | 70 | −21 |
| Stock-based pay | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Free cash flow after stock pay | −13 | −18 | 32 | −14 | 14 | 14 | 68 | −23 |
| Last 12 months unless stated | SWBI | RGR | JOUT | CRCT | MCFT | MBUU | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $551m | $577m | $661m | $690m | $349m | $915m | $349m |
| Revenue growth, last 12 months | 17.0% | 7.6% | 17.5% | −3.1% | 22.8% | 13.3% | 7.6% |
| Revenue growth, 3-year average | 2.7% | −0.2% | −4.7% | −5.5% | −19.2% | −13.0% | −2.5% |
| Revenue growth, latest quarter | 32.3% | 19.3% | 5.0% | −9.2% | 63.4% | 42.7% | 10.9% |
| Gross margin | 27.4% | 18.7% | 39.7% | 57.9% | 22.9% | 16.0% | 40.1% |
| Operating margin | 6.6% | 1.0% | 2.7% | 15.5% | −0.3% | 0.3% | 1.0% |
| Operating margin, 3-year average | 6.5% | 2.6% | −3.5% | 13.2% | 4.1% | −1.2% | 0.9% |
| Net margin | 4.4% | 2.1% | −1.2% | 12.7% | −0.5% | 0.2% | −0.5% |
| Cash from operations / revenue | 20.6% | 11.2% | 7.6% | 26.1% | 8.7% | 7.4% | 8.7% |
| Free-cash-flow margin | 14.9% | 8.2% | 4.5% | 22.6% | 6.4% | 4.7% | 6.1% |
| Free-cash-flow margin, 3-year average | 2.7% | 7.7% | 3.5% | 27.5% | 5.4% | 1.9% | 5.3% |
| Stock pay / revenue | 1.5% | 0.9% | 0.5% | 3.9% | 1.2% | 0.6% | 1.3% |
| Change in share count | −6.8% | −4.2% | 0.8% | 0.9% | 3.9% | −1.8% | 0.5% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 17.0% | 7.6% | 9 of 29 |
| Change in growth rate Growth | +6.6pp | +3.1pp | 7 of 29 |
| Gross margin Profitability | 27.4% | 39.7% | 19 of 27 |
| Operating margin Profitability | 6.6% | 1.0% | 9 of 29 |
| Net margin Profitability | 4.4% | -0.5% | 9 of 29 |
| Free-cash-flow margin Cash generation | 14.9% | 6.1% | 8 of 29 |
| Stock pay as % of revenue Cash generation | 1.5% | 1.3% | 15 of 27 |
| Days sales outstanding Balance sheet | 20 days | 42 days | 7 of 27 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Product One | $394M | 75.3% | ▲ 18.8% |
| Product Two | $90.5M | 17.3% | ▼ 13.0% |
| Other Products and Services | $39M | 7.4% | ▲ 0.5% |
| Region | Revenue | YoY |
|---|---|---|
| International | $20.9M | ▼ 9.5% |
| Europe | $9.6M | ▲ 36.5% |
| Asia | $4.9M | ▼ 39.8% |
| Other International | $4.5M | ▼ 29.8% |
| Latin America | $1.9M | ▲ 28.5% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Smith & Wesson Brands, Inc.'s 10-K filed June 17, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Blackrock, Inc. | $61.5M | 4.1M | 14.1% | ▲ 4.0% |
| Dimensional Fund Advisors LP | $40.3M | 2.7M | 9.2% | ▲ 2.4% |
| Renaissance Technologies LLC | $33.4M | 2.2M | 7.6% | ▲ 3.2% |
| Vanguard Capital Management LLC | $28.6M | 1.9M | 6.5% | ▲ 2.3% |
| Two Sigma Investments, LP | $26.5M | 1.8M | 6.1% | ▲ 6.2% |
| Geode Capital Management, LLC | $19.8M | 1.3M | 4.5% | ▲ 18.5% |
| Charles Schwab Investment Management Inc | $14.9M | 994K | 3.4% | ▼ 17.7% |
| Goldman Sachs Group Inc | $14.7M | 976K | 3.4% | ▲ 83.0% |
| State Street Corp | $14.1M | 937K | 3.2% | ▲ 11.7% |
| Arrowstreet Capital, Limited Partnership | $12.9M | 855K | 2.9% | ▲ 134.2% |
| Qube Research & Technologies Ltd | $12.3M | 815K | 2.8% | New |
| American Century Companies Inc | $11.4M | 757K | 2.6% | ▲ 71.7% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Smith & Wesson Brands, Inc.'s complete shareholder register. Values are as reported by the filers .
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Next expected around December 3, 2026 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
